Milestone Scientific (MLSS) Change in Account Payables (2010 - 2026)
Milestone Scientific (MLSS) reported Change in Account Payables of -$366824.0 for Q1 2026, down 237.09% on a YoY basis from $267575.0 in Q1 2025, and down 193.01% sequentially from -$125191.0 in Q4 2025.
Milestone Scientific (MLSS) Change in Account Payables (2010 - 2026) Analysis & Trends
Milestone Scientific (MLSS) has 17 years of Change in Account Payables data on file, last reported at -$366824.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 237.09% year-over-year to -$366824.0; the trailing twelve-month figure through Mar 2026 stood at -$225543.0 (down 222.99% YoY), and the FY2025 full-year result was $408856.0, up 23.23% from the prior year.
- Change in Account Payables retreated to -$366824.0 in Q1 2026, from -$125191.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $733062.0 in Q1 2022 to a low of -$395261.0 in Q2 2022.
- A 5-year average of $22851.5 and a median of -$76221.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 490.39% in 2024 and plunged 5578.82% in 2025, its largest moves.
- Tracing MLSS's Change in Account Payables over 5 years: stood at -$94656.0 in 2022, then tumbled by 138.89% to -$226126.0 in 2023, then surged by 101.01% to $2285.0 in 2024, then sank by 5578.82% to -$125191.0 in 2025, then plunged by 193.01% to -$366824.0 in 2026.
- Business Quant data shows MLSS's Change in Account Payables at -$366824.0 in Q1 2026, -$125191.0 in Q4 2025, and $521905.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Milestone Scientific | 33.00 Mn | 31.35 Mn | 1.56 Mn | -366,824.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -366,824.00 |
| Mar 31, 2026 | -366,824.00 |
| Dec 31, 2025 | -125,191.00 |
| Dec 31, 2025 | -125,191.00 |
| Sep 30, 2025 | 521,905.00 |
| Sep 30, 2025 | 521,905.00 |
| Jun 30, 2025 | -255,433.00 |
| Jun 30, 2025 | -255,433.00 |
| Mar 31, 2025 | 267,575.00 |
| Mar 31, 2025 | 267,575.00 |
| Dec 31, 2024 | 2,285.00 |
| Dec 31, 2024 | 2,285.00 |
| Sep 30, 2024 | -384,029.00 |
| Sep 30, 2024 | -384,029.00 |
| Jun 30, 2024 | 297,559.00 |
| Jun 30, 2024 | 297,559.00 |
| Mar 31, 2024 | 415,974.00 |
| Mar 31, 2024 | 415,974.00 |
| Dec 31, 2023 | -226,126.00 |
| Dec 31, 2023 | -226,126.00 |